1 FORWARD-LOOKING STATEMENTS 1 OVERVIEW 2 THERAPLAS MODALITY: IMNN-001 DEVELOPMENT PROGRAM 2 Ovarian Cancer Overview 2 IMNN-001 Immunotherapy 3 OVATION I Study 3 OVATION 2 Study 5 OVATION 3 Study 8 IMNN-001 in Combination with Bevacizumab 9 PLACCINE DNA VACCINE MODALITY: IMNN-101 9 Our Next Generation Vaccine Initiative 10 BUSINESS STRATEGY AND DEVELOPMENT PLAN 12 RESEARCH AND DEVELOPMENT EXPENDITURES 13 GOVERNMENT REGULATION 14 MANUFACTURING AND SUPPLY 24 SALES AND MARKETING 24 PRODUCT LIABILIT...
Q2 FY2026 — expected 2026-08-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-31 | 2025-12-31 | 0001493152-26-013850 | EDGAR | 74K words |
| 2025-02-27 | 2024-12-31 | 0001493152-25-008460 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0001493152-24-011616 | EDGAR | — |
| 2023-03-30 | 2022-12-31 | 0001493152-23-009604 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001493152-22-008277 | EDGAR | — |
| 2021-03-19 | 2020-12-31 | 0001493152-21-006382 | EDGAR | — |
| 2020-03-25 | 2019-12-31 | 0001493152-20-004717 | EDGAR | — |
| 2019-03-29 | 2018-12-31 | 0001493152-19-004184 | EDGAR | — |
| 2018-03-27 | 2017-12-31 | 0001437749-18-005539 | EDGAR | — |
| 2017-03-24 | 2016-12-31 | 0001437749-17-005235 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001493152-25-022120 | EDGAR | 26K words |
| 2025-08-05 | 2025-06-30 | 0001493152-25-011598 | EDGAR | — |
| 2025-05-12 | 2025-03-31 | 0001641172-25-009572 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001493152-24-043931 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0001493152-24-031916 | EDGAR | — |
| 2024-05-13 | 2024-03-31 | 0001493152-24-018795 | EDGAR | — |
| 2023-11-14 | 2023-09-30 | 0001493152-23-040803 | EDGAR | — |
| 2023-08-10 | 2023-06-30 | 0001493152-23-027457 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001493152-23-016299 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031641 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001493152-22-022599 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001493152-22-013522 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-31 | 0001493152-26-013816 | EDGAR | 3K words |
| 2026-03-23 | 0001493152-26-012164 | EDGAR | — |
| 2026-02-05 | 0001493152-26-005203 | EDGAR | — |
| 2026-01-07 | 0001493152-26-000841 | EDGAR | — |
| 2025-12-31 | 0001493152-25-029711 | EDGAR | — |
| 2025-11-13 | 0001493152-25-022118 | EDGAR | — |
| 2025-08-28 | 0001493152-25-012417 | EDGAR | — |
| 2025-08-05 | 0001493152-25-011597 | EDGAR | — |
| 2025-07-28 | 0001493152-25-011440 | EDGAR | — |
| 2025-07-23 | 0001641172-25-020652 | EDGAR | — |
401 total filings indexed. 369 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000749647 |
| Ticker | IMNN |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.imunon.com |
| Listed | 1995-07-24 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/IMNN (~200 tokens, structured JSON with cryptographic provenance)